written on 23.02.2017

Singapore Pharma Report


This report offers companies, investors, policymakers, and stakeholders crucial insight into Singapore; a nation that has had to carve out its own niche as a global trade hub and gateway to the Asia-Pacific region to compete globally since declaring independence in 1965. In terms of healthcare and life sciences, the island now serves as a regional hub for myriad multinationals, stands at the forefront of cutting-edge scientific research and development, and is globally renowned in several important levels of the pharmaceutical supply chain.

The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on Singapore’s healthcare and pharma sectors.

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here